Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Can we reduce cardiovascular deaths by preventing a recurrence of atrial fibrillation? Dr. Eric Prystowsky, Director of Electrophysiology at St. Vincent Hospital in Indianapolis, Indiana, will discuss the results of the ATHENA trial; a study using dronedarone, an amiodarone-like medication, that was shown to significantly reduce cardiovascular deaths and hospitalizations due to atrial fibrillation and acute coronary syndromes. Join host Dr. Matthew Sorrentino.
Can we reduce cardiovascular deaths by preventing a recurrence of atrial fibrillation? Dr. Eric Prystowsky, Director of Electrophysiology at St. Vincent Hospital in Indianapolis, Indiana, will discuss the results of the ATHENA trial; a study using dronedarone, an amiodarone-like medication, that was shown to significantly reduce cardiovascular deaths and hospitalizations due to atrial fibrillation and acute coronary syndromes. Join host Dr. Matthew Sorrentino.
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Love Story: Lipid Education for Women’s Heart Health
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Stay current with the best on medical education
